Oak Street Health, Inc. (NYSE:OSH – Get Valuation) COO Brian Clem sold 6,601 shares of the company in a deal on Thursday, Jan. 12. The stock sold at an average price of $30.02, for a total transaction of $198,162.02. Following the completion of the transaction, the chief operating officer now owns 489,577 shares of the company, valued at $14,697,101.54. The sale was disclosed in a filing with the SEC, available at this link.
Brian Clem also recently made the following trades:
- On Tuesday, January 10, Brian Clem sold 17,569 shares of Oak Street Health. The shares sold at an average price of $28.88, for a total transaction of $507,392.72.
- On Tuesday, January 3, Brian Clem sold 5,000 shares of Oak Street Health. The stock sold at an average price of $24.02, for a total transaction of $120,100.00.
- On Thursday, December 1, Brian Clem sold 5,000 shares of Oak Street Health. The stock sold at an average price of $21.83, for a total value of $109,150.00.
- On Tuesday, November 1, Brian Clem sold 5,000 shares of Oak Street Health. The shares sold at an average price of $20.57, for a total value of $102,850.00.
Oak Street Health stocks up 0.4%
Shares of Oak Street Health rose $0.11 on Friday to hit $30.05. The company’s stock had trading volume of 4,580,634 shares, compared to its average trading volume of 4,684,848. Oak Street Health, Inc. has a 52-week low of $13.29 and a 52-week high of $30.89. The company’s fifty-day simple moving average is $21.46, and its two hundred-day simple moving average is $23.50. The company has a market cap of $7.30 billion, a price-earnings ratio of -13.19, and a beta of 2.18.
Oak Street Health (NYSE:OSH – Get Rating) last released its quarterly earnings data on Monday, Nov. 7. The company reported ($0.56) EPS for the quarter, beating the ($0.63) consensus estimate by $0.07. Oak Street Health had a negative return on equity of 1,883.59% and a negative net margin of 26.04%. The company reported revenue of $545.70 million for the quarter, versus analyst expectations of $540.28 million. As a group, research analysts expect Oak Street Health, Inc. to post -2.26 EPS for the current year.
Oak Street Health Institutional Trading
Several large investors have recently made changes to their positions on OSH. Heritage Wealth Management LLC purchased a new location in Oak Street Health during the second quarter valued at approximately $58,000. Captrust Financial Advisors increased its stake in Oak Street Health by 114.5% during the first quarter. Captrust Financial Advisors now owns 2,688 shares of the company valued at $72,000 after purchasing an additional 1,435 shares during the most recent quarter. PNC Financial Services Group Inc. increased its holdings of Oak Street Health stock by 1,496.3% during the first quarter. PNC Financial Services Group Inc. now owns 3,480 shares of the company valued at $93,000 after purchasing an additional 3,262 shares during the period. MetLife Investment Management LLC purchased a new position in Oak Street Health stock in the first quarter for $159,000. Finally, Wealthspire Advisors LLC purchased a new position in Oak Street Health stock in the second quarter for $164,000. 92.04% of the stock is currently held by institutional investors.
Analysts set new price targets
Several stock analysts have commented on OSH stock. Raymond James upgraded Oak Street Health from a “market performance” rating to an “outperform” rating and set a $35.00 price target for the company in a research report Thursday. Canaccord Genuity Group lowered Oak Street Health’s stock price target from $32.00 to $27.00 in a research report on Wednesday, Nov. 9. Morgan Stanley upgraded shares of Oak Street Health from an “equal weight” rating to an “overweight” rating in a report on Monday, Nov. 14. UBS Group lowered Oak Street Health’s share price target from $28.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, Jan. 6. Finally, SVB Leerink raised its price target on Oak Street Health from $23.00 to $33.00 and gave the stock a “market performance” rating in a research note Tuesday. One research analyst rated the stock with a sell rating, five gave a hold rating, and seven gave the company a buy rating. According to MarketBeat.com, Oak Street Health currently has an average rating of “Hold” and an average price target of $31.07.
Oak Street Health Information
(Get Rating)
Oak Street Health, Inc, together with its subsidiaries, provides healthcare services to patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio and Texas.
Further reading
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Oak Street Health, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and best-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Oak Street Health wasn’t on the list.
Although Oak Street Health currently has a “Hold” rating among analysts, senior analysts believe these five stocks are better buys.
View the five titles here
